Women with Schizophrenia over the Life Span: Health Promotion, Treatment and Outcomes.
antipsychotics
gender
psychosis
schizophrenia
women
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
03 08 2020
03 08 2020
Historique:
received:
16
06
2020
revised:
22
07
2020
accepted:
30
07
2020
entrez:
7
8
2020
pubmed:
7
8
2020
medline:
18
11
2020
Statut:
epublish
Résumé
Women with schizophrenia show sex-specific health needs that differ according to stage of life. The aim of this narrative review is to resolve important questions concerning the treatment of women with schizophrenia at different periods of their life-paying special attention to reproductive and post-reproductive stages. Review results suggest that menstrual cycle-dependent treatments may be a useful option for many women and that recommendations re contraceptive options need always to be part of care provision. The pregnancy and the postpartum periods-while constituting vulnerable time periods for the mother-require special attention to antipsychotic effects on the fetus and neonate. Menopause and aging are further vulnerable times, with extra challenges posed by associated health risks. Pregnancy complications, neurodevelopmental difficulties of offspring, cancer risk and cognitive defects are indirect results of the interplay of hormones and antipsychotic treatment of women over the course of the lifespan. The literature recommends that health promotion strategies need to be directed at lifestyle modifications, prevention of medical comorbidities and increased psychosocial support. Careful monitoring of pharmacological treatment has been shown to be critical during periods of hormonal transition. Not only does treatment of women with schizophrenia often need to be different than that of their male peers, but it also needs to vary over the course of life.
Identifiants
pubmed: 32756418
pii: ijerph17155594
doi: 10.3390/ijerph17155594
pmc: PMC7432627
pii:
doi:
Substances chimiques
Antipsychotic Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
JL has received honoraria for lectures or advisory board membership from Janssen, Otsuka, Lundbeck and Angelini. AGR, AGD, AA and MB have received honoraria or travel funds for congresses from Janssen, Otsuka, Lundbeck and Angelini.
Références
Psychiatry J. 2019 Apr 16;2019:9804836
pubmed: 31139639
Expert Opin Drug Saf. 2014 Oct;13(10):1353-60
pubmed: 25227335
Int J Endocrinol. 2015;2015:615356
pubmed: 26491441
Eur Arch Psychiatry Clin Neurosci. 2020 Sep;270(6):729-737
pubmed: 31728631
Psychiatr Q. 2019 Sep;90(3):553-563
pubmed: 31147816
J Gen Intern Med. 2006 Nov;21(11):1133-7
pubmed: 17026726
Life Sci. 2018 Jan 1;192:190-198
pubmed: 29191645
Psychiatry Res. 2019 Oct;280:112510
pubmed: 31415936
Psychopharmacology (Berl). 2017 Nov;234(22):3279-3297
pubmed: 28889207
Curr Opin Psychiatry. 2020 May;33(3):192-199
pubmed: 32068570
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109941
pubmed: 32243999
Can J Clin Pharmacol. 2009 Winter;16(1):e23-32
pubmed: 19164844
Vascul Pharmacol. 2018 Jan;100:20-25
pubmed: 28888918
Arch Gynecol Obstet. 2019 Oct;300(4):889-896
pubmed: 31410569
Menopause. 2017 May;24(5):582-588
pubmed: 27824682
Evid Based Ment Health. 2011 Feb;14(1):31
pubmed: 21266628
J Psychiatr Pract. 2011 Jul;17(4):258-69
pubmed: 21775827
Fam Plann Perspect. 1992 Jan-Feb;24(1):27-32, 48
pubmed: 1294072
Transl Clin Pharmacol. 2019 Dec;27(4):127-133
pubmed: 32095480
J Psychiatr Res. 2017 Dec;95:84-90
pubmed: 28810177
Neuropharmacology. 2020 Feb;163:107631
pubmed: 31077728
Psychiatr Serv. 2003 Jun;54(6):902-4
pubmed: 12773608
Lancet. 2014 Nov 15;384(9956):1789-99
pubmed: 25455249
Lancet Psychiatry. 2020 Jan;7(1):52-63
pubmed: 31787585
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:263-271
pubmed: 29122637
Aust N Z J Obstet Gynaecol. 2020 Feb;60(1):63-69
pubmed: 31141172
Eur Child Adolesc Psychiatry. 2019 Jun;28(6):759-767
pubmed: 30382356
Eur J Clin Pharmacol. 2020 Jan;76(1):107-115
pubmed: 31680189
Curr Psychiatry Rep. 2017 Sep 14;19(11):77
pubmed: 28905259
Psychoneuroendocrinology. 2018 Oct;96:173-178
pubmed: 29980009
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Early Interv Psychiatry. 2020 Aug;14(4):418-427
pubmed: 31414567
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Apr 20;99:109863
pubmed: 31931089
Arch Womens Ment Health. 2016 Dec;19(6):1019-1027
pubmed: 27511109
Cancer Causes Control. 2017 Dec;28(12):1441-1452
pubmed: 29086892
BJOG. 2014 Apr;121(5):566-74
pubmed: 24443970
Acta Psychiatr Scand. 2016 Oct;134(4):305-13
pubmed: 27437875
Gen Hosp Psychiatry. 2008 Mar-Apr;30(2):177-84
pubmed: 18291300
Schizophr Res. 2019 Oct;212:86-91
pubmed: 31420202
Schizophr Res. 2004 Nov 1;71(1):49-60
pubmed: 15374572
Indian J Psychol Med. 2019 Jul-Aug;41(4):323-330
pubmed: 31391664
Rev Colomb Psiquiatr. 2020 Jan - Mar;49(1):15-22
pubmed: 32081203
Curr Diab Rep. 2018 Jul 30;18(9):69
pubmed: 30058013
Arch Womens Ment Health. 2017 Oct;20(5):613-620
pubmed: 28702774
BMC Res Notes. 2019 Sep 27;12(1):635
pubmed: 31558159
Schizophr Bull. 2018 Oct 17;44(6):1195-1203
pubmed: 29762765
Expert Opin Pharmacother. 2018 Jun;19(8):809-821
pubmed: 29676942
Schizophr Res Treatment. 2012;2012:796763
pubmed: 22966446
J Womens Health (Larchmt). 2019 Mar;28(3):339-345
pubmed: 30767686
Schizophr Res. 2018 Dec;202:316-321
pubmed: 29954703
Int J Soc Psychiatry. 2019 May;65(3):183-193
pubmed: 30848686
Endocrinol Metab Clin North Am. 2015 Sep;44(3):485-96
pubmed: 26316238
Curr Opin Psychiatry. 2017 May;30(3):184-190
pubmed: 28306564
J Clin Psychiatry. 2017 May;78(5):e477-e489
pubmed: 28297592
Expert Opin Pharmacother. 2019 Aug;20(11):1365-1376
pubmed: 31090482
Schizophr Bull. 2010 May;36(3):518-44
pubmed: 18787227
Acta Psychiatr Scand. 2012 May;125(5):363-71
pubmed: 22235755
Expert Opin Pharmacother. 2017 Nov;18(16):1703-1719
pubmed: 29019422
Psychiatry Res. 2019 Mar;273:9-14
pubmed: 30639565
J Clin Psychopharmacol. 2016 Dec;36(6):580-587
pubmed: 27626286
Br J Psychiatry. 2015 Dec;207(6):515-22
pubmed: 26450584
J Psychosom Obstet Gynaecol. 1998 Dec;19(4):210-7
pubmed: 9929847
Aust N Z J Psychiatry. 2016 May;50(5):481-7
pubmed: 26070315
Obstet Gynecol. 2011 Dec;118(6):1331-6
pubmed: 22105263
Psychiatry Clin Neurosci. 2019 Jul;73(7):376-385
pubmed: 31026107
Int Psychogeriatr. 2020 Jun 19;:1-19
pubmed: 32618553
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158534
pubmed: 31672575
J Psychopharmacol. 2010 Jul;24(7):953-64
pubmed: 19939865
Obstet Gynecol. 2015 May;125(5):1224-35
pubmed: 25932852
World J Psychiatry. 2018 Nov 9;8(5):125-136
pubmed: 30425943
Lancet. 2015 Nov 7;386(10006):1845-52
pubmed: 26318519
Schizophr Res Treatment. 2012;2012:916198
pubmed: 22966451
Int J Soc Psychiatry. 2020 May;66(3):225-231
pubmed: 31902275
J Am Osteopath Assoc. 2002 Dec;102(12):655-9
pubmed: 12501982
J Womens Health (Larchmt). 2006 May;15(4):352-68
pubmed: 16724884
Psychiatr Pol. 2019 Aug 31;53(4):955-966
pubmed: 31760419